endolinx Medical News about type I diabetes

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Endocrinology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Endocrinology

Adrenal Glands

Atherosclerosis/Lipids

Basic Science/Genetics

Bone Metabolism

Diabetes

Diagnostics

Economics of Medicine

Endocrine Oncology

Fetal Development

Hypertension

Metabolism and Growth

Neuroendocrinology

Obesity

Pediatric Endocrinology

Pharmacology/kinetics

Popular Press

Reproductive
Endocrinology

Thyroid/Parathyroid

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes
Clinical and Experimental Immunology, 05/14/08

Email This Article

Save in My Library

Free Abstract

Huurman VAL et al. - Immunological monitoring distinguished therapy from placebo treatment and could determine immunological efficacy. Declining or temporary proliferative responses to peptide DiaPep277 treatment may serve as an immunological biomarker for clinical efficacy.

Sponsor

--- DIABETES TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

A novel insulin formulation with a more rapid onset of action
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 07/22/08

Is Fluid Therapy Associated With Cerebral Edema in Children With Diabetic Ketoacidosis?
Annals of Emergency Medicine, 06/19/08

Routine glutamic acid decarboxylase autoantibody (GADA) testing: patients' perspective
Family Practice, 06/30/08

...All of Diabetes